WWC2 and age-related macular degeneration: Since both ocular disease therapies, such as AMD and PDR, and beyond that, cancer treatment, use the protective and beneficial effects of anti-angiogenic therapies, the knowledge we gained about WWC2 as a crucial regulator is of great relevance and importance.